Descriptions:
Term | description type | Language/acceptability | Language/acceptability | Case Significance |
---|---|---|---|---|
Product containing [substance] in [pharmaceutical dose form] (medicinal product form) | FSN | us:P | gb:P | ci |
[substance]-containing product in [pharmaceutical dose form] | SYN | us:P | gb:P | ci |
Concept model:
Role group cardinality | Attribute cardinality | Attribute in role group cardinality | Attribute | Value |
---|---|---|---|---|
0..0 | 1..1 | |||
0..0 | 1..1 | |||
1..* | 1..1 |
Definition status:
Rules for description generation:
- Apply General rules for generating descriptions for templates
- 'and [substance]' needs to be added for FSN for multiple |has active ingredient| and they are self grouped, e.g. Product containing calcium carbonate and light kaolin in oral dose form (medicinal product form)
- '[substance]- and' needs at the beginning of the description to be added for PT for multiple |has active ingredient| and they are self grouped, e.g. calcium carbonate- and light kaolin-containing product in oral dose form
- For multiple ingredients, the ingredients in each description need to be in alphabetical order e.g. Codeine and paracetamol for FSN but Acetaminophen and codeine (for US PT).
Template Language
763158003 |Medicinal product (product)|
:
[[1..1]] 411116001 |Has manufactured dose form (attribute)| = < 736542009 |Pharmaceutical dose form (dose form)| ,
[[~1..*]] {[[~1..1]] 762949000 |Has precise active ingredient (attribute)| = [[ +id( < 105590001 |Substance (substance)| ) @ingred]]}
[[1..1]] 411116001 |Has manufactured dose form (attribute)| = < 736542009 |Pharmaceutical dose form (dose form)| ,
[[~1..*]] {[[~1..1]] 762949000 |Has precise active ingredient (attribute)| = [[ +id( < 105590001 |Substance (substance)| ) @ingred]]}
JIRA ticket for implementation:
- DRUGS-275Getting issue details... STATUS